Clinical Trial Update: Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma

View source ↗

Summary

A completed clinical trial reports retinal changes associated with BRAF/MEK inhibitor therapy in patients with malignant melanoma, highlighting potential ocular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Dabrafenib (Tafinlar) (dabrafenib)
• Trametinib (Mekinist) (trametinib)

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Malignant Melanoma, Drug-Induced Retinopathy | Status: COMPLETED